ClinicalTrials HQ

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

Recruiting · NCT07288034 · Registry updated 2026-04-15
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP TrialNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 22026-04-15NCT07288034

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
City of Hope Medical Center347
National Cancer Institute (NCI)3015

13 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
City of Hope Antelope ValleyLancasterUnited States52
City of Hope at ChicagoZionUnited States6
City of Hope at Irvine LennarIrvineUnited States104
City of Hope at Long Beach ElmLong BeachUnited States22
City of Hope at Newport Beach Fashion IslandNewport BeachUnited States5
City of Hope Atlanta Cancer CenterNewnanUnited States8
City of Hope CoronaCoronaUnited States22
City of Hope Medical CenterDuarteUnited States313
City of Hope SeacliffHuntington BeachUnited States16
City of Hope South BayTorranceUnited States28
City of Hope South PasadenaSouth PasadenaUnited States77
City of Hope UplandUplandUnited States69
CTCA at Western Regional Medical CenterGoodyearUnited States44